CLASS III Drug recall · Reported 18 Oct 2017 · FDA Enforcement Report
Mobic (meloxicam) tablets, 15 mg, package recalled
Boehringer Ingelheim Pharmaceuticals is recalling Mobic (meloxicam) tablets, 15 mg, package, distributed in Colorado, Ohio. The recall was initiated on 22 Sep 2017 and the FDA has classified it as Class III.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0007-2018
- FDA event ID
- 78172
- Recalling firm
- Boehringer Ingelheim Pharmaceuticals, Danbury, CT
- Classification
- Class III
- Status
- Terminated
- Recall initiated
- 22 Sep 2017
- FDA classified
- 6 Oct 2017
- Reported
- 18 Oct 2017
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Packaging Defects
- Drug class
- Pain Medication
Timeline
| 22 Sep 2017 | Recall initiated by company | |
| 6 Oct 2017 | Classified by FDA | +14 days |
| 18 Oct 2017 | Published in enforcement report | +12 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.
Product as listed by the FDA
Mobic (meloxicam) tablets, 15 mg, package in 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877 USA, Lic. from: BI Int'l GmbH, Made in Italy, NDC 0597-0030-01
Where it was distributed
CO, OH
Questions about this recall
Why was it recalled?
Labeling: Incorrect or missing package insert. One lot of Mobic Tablets is packaged with an incorrect insert.
Which lots are affected?
Lot 754037
Where was it sold?
CO, OH
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class III mean?
Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.